The clinical development process isn’t easy. It’s riddled with complexity and risk, which can cost your organization significant time and money. GRA offers a variety of clinical research services that bring together our global clinical and regulatory expertise with proprietary technologies to simplify your journey to market. The benefit for you is reduced development costs while minimizing risks of late phase failure.

It typically takes several years for a potential new therapy or healthcare device to gain approval for use within patients. And trials conducted during development generate thousands of pieces of data that are generally used by regulatory agencies, such as the US Food and Drug Administration (FDA) to determine approval for use of the therapy and in which medical indications.

Our clinical trial development processes facilitate commercial efficiency and cost effectiveness in helping bring clients’ products to market. We are used to working with clients who have to be efficient with their resources. GRA is flexible in working in changing environments and are able to manage your clinical programme from concept, through to marketing application if required.

Whatever the size or scope of your study, GRA provides the comprehensive clinical development services you need, from First-in-Human through Phase IV and post-marketing follow-through. We also have the regulatory expertise, clinical trial operations management, payer and market access planning, medical education and communications capabilities to see your journey through efficiently and effectively.

o

o

o

We take a holistic and integrated view of what is happening in lifesciences today and help your company to manage the future.